Scientific Journals Articles Nov 2014
Articles can be sourced by searching with the doi.
Journal membership is required to access some of the papers, others are free to access.
Somatic Mutations and Immunotherapy Outcome with CTLA-4 Blockade in Melanoma
Vassiliki A. Boussiotis, M.D., Ph.D.
November 19, 2014
DOI: 10.1056/NEJMe1413061
67-kDa Laminin Receptor-dependent Protein Phosphatase 2A (PP2A) Activation Elicits Melanoma-specific Antitumor Activity Overcoming Drug Resistance
Shuntaro Tsukamoto, Yuhui Huang, Daisuke Umeda, Shuhei Yamada, Shuya Yamashita, Motofumi Kumazoe, Yoonhee Kim, Motoki Murata, Koji Yamada and Hirofumi Tachibana
- Biol. Chem. 2014, 289:32671-32681.
originally published online October 7, 2014
doi: 10.1074/jbc.M114.604983
?-Actinin-4 Is Required for Amoeboid-type Invasiveness of Melanoma Cells*
The Journal of Biological Chemistry, 2014, 289: 32717-32728.
First Published onOctober 8, 2014,
5November 21, 2014
doi:10.1074/jbc.M114.57918
Ipilimumab Plus Sargramostim vs Ipilimumab Alone for Treatment of Metastatic Melanoma. A Randomized Clinical Trial
- Stephen Hodi, MD1; Sandra Lee, ScD2,3; David F. McDermott, MD4,5; Uma N. Rao, MD6; Lisa H. Butterfield, PhD7; Ahmad A. Tarhini, MD, PhD7; Philip Leming, MD8,9; Igor Puzanov, MD10; Donghoon Shin, SM2,3; John M. Kirkwood, MD7
JAMA. 2014;312(17):1744-1753.
doi:10.1001/jama.2014.13943.
Therapy Preferences in Melanoma Treatment – Willingness to Pay and Preference of Quality versus Length of Life of Patients, Physicians and Healthy Controls
- Ramona Krammer, Lucie Heinzerling
- Published: November 04, 2014
PLOS one
DOI: 10.1371/journal.pone.0111237
Parallel In Vivo and In Vitro Melanoma RNAi Dropout Screens Reveal Synthetic Lethality between Hypoxia and DNA Damage Response Inhibition
Patricia A. Possik, Judith Müller, Carmen Gerlach5, Juliana C.N. Kenski,, Xinyao Huang, Aida Shahrabi, Oscar Krijgsman, Ji-Ying Song, Marjon A. Smit6,Bram Gerritsen7, Cor Lieftink, Kristel Kemper, Magali Michaut, Roderick L. Beijersbergen, Lodewyk Wessels, Ton N. Schumacher, Daniel S. Peeper
Cell Reports
DOI: http://dx.doi.org/10.1016/j.celrep.2014.10.024
Melanoma progression is associated with NK cell exhaustion
Ines Pires da Silva, Anne Gallois, Sonia Jimenez-Baranda, Ana Anderson, Vijay Kuchroo, Iman Osman, Nina Bhardwaj*
From Society for Immunotherapy of Cancer 29th Annual Meeting, National Harbor, MD, USA. 6-9 November 2014
Journal for ImmunoTherapy of Cancer 2014, 2(Suppl 3):O6
doi:10.1186/2051-1426-2-S3-O6
Response to MAPK pathway inhibitors in BRAF V600M-mutated metastatic melanoma
- Parakh Bsc MbChB*,C. Murphy MBBS, D. Lau MBBS FRACP, J. S. Cebon MBBS PhD FRACP and M. C. Andrews Bsc (Honours) MBBS FRACP
Article first published online: 10 NOV 2014
Journal of Clinical Pharmacy and Therapeutics
DOI: 10.1111/jcpt.12229
CYP24A1 Expression Inversely Correlates with Melanoma Progression: Clinic-Pathological Studies
Anna A. Bro?yna, Cezary Jochymski, Zorica Janjetovic, Wojciech Jó?wicki , Robert C. Tuckey and Andrzej T. Slominski
Open Access Int. J. Mol. Sci. 2014, 15, 19000-19017;
doi:10.3390/ijms151019000
Rapid Evolution of Combination Therapy in Melanoma
Brendan D. Curti, M.D.
N Engl J Med 2014; 371:1929-1930
November 13, 2014
DOI: 10.1056/NEJMe1411158
Nivolumab in Previously Untreated Melanoma without BRAFMutation
Caroline Robert, M.D., Ph.D., Georgina V. Long, M.D., Ph.D., Benjamin Brady, M.D., Caroline Dutriaux, M.D., Michele Maio, M.D., Laurent Mortier, M.D., Jessica C. Hassel, M.D., Piotr Rutkowski, M.D., Ph.D., Catriona McNeil, M.D., Ph.D., Ewa Kalinka-Warzocha, M.D., Ph.D., Kerry J. Savage, M.D., Micaela M. Hernberg, M.D., Ph.D., Celeste Lebbé, M.D., Ph.D., Julie Charles, M.D., Ph.D., Catalin Mihalcioiu, M.D., Vanna Chiarion-Sileni, M.D., Cornelia Mauch, M.D., Ph.D., Francesco Cognetti, M.D., Ana Arance, M.D., Ph.D., Henrik Schmidt, M.D., D.M.Sc., Dirk Schadendorf, M.D., Helen Gogas, M.D., Lotta Lundgren-Eriksson, M.D., Christine Horak, Ph.D., Brian Sharkey, Ph.D., Ian M. Waxman, M.D., Victoria Atkinson, M.D., and Paolo A. Ascierto, M.D.
November 16, 2014
DOI: 10.1056/NEJMoa1412082